ListedMainboardEMCURE

Emcure Pharmaceuticals IPO

Emcure Pharmaceuticals IPO is a mainboard IPO raising ₹1,952 Cr at ₹960 – ₹1,008 a share. It listed on 10 Jul 2024 and trades at ₹1,893 today, +87.8% against its issue price of ₹1,008. It was subscribed 68× in total.

1,008
Issue price
1,893
Price now
+87.8%
Since issue price
10 Jul 2024
Listed on
68×Subscribed (final) · all exchanges

67.9 times more demand than shares on offer

populated partly populated we hold nothing here — the tab says why

Who bid for it

Investor categoryShares offeredShares bid forSubscribed
QIB
Banks, funds and other large institutions
37,62,89673,68,91,932196×
Foreign Institutional Investorsno separate quota24,04,51,134n/a
Domestic Financial Institutionsno separate quota31,88,70,594n/a
Mutual fundsno separate quota6,71,67,898n/a
Othersno separate quota11,04,02,306n/a
Non-institutional
Wealthy individuals and companies bidding above ₹2 lakh
29,49,52314,25,26,74848×
Non Institutional Investors19,66,34910,57,70,49054×
Corporatesno separate quota16,46,078n/a
Individualsno separate quota9,35,71,240n/a
Othersno separate quota1,05,53,172n/a
Non Institutional Investors9,83,1743,67,56,25837×
Corporatesno separate quota86,674n/a
Individualsno separate quota3,25,33,354n/a
Othersno separate quota41,36,230n/a
Retail
Ordinary investors bidding up to ₹2 lakh
68,82,2194,96,18,9827.21×
Cut Offno separate quota4,38,22,198n/a
Price bidsno separate quota57,96,784n/a
Employees1,08,9009,59,7288.81×
Cut Offno separate quota8,49,282n/a
Price Bidsno separate quota1,10,446n/a
Total1,37,03,53892,99,97,39068×

Sub-categories read no separate quota rather than a dash: the exchange publishes bids at that level but never a reservation against them, so a subscription multiple does not exist — it is not missing data. Bids across both exchanges (NSE and BSE) — the figure usually quoted publicly. Last updated 25 Jul, 06:49 pm IST.

How demand built

We hold no subscription readings for this issue.